Arcadia Biosciences logo

Arcadia Biosciences (RKDA) Q1 2026 Annual Earnings

RKDA·Reported May 14, 2026·Before market open

Arcadia Biosciences reported Q1 2026 revenue of $1.1M (-8.3% YoY), missed analyst consensus of $1.6M by $500.0K. Diluted EPS came in at $-2.11, missed the $-0.80 consensus by $1.31.

Revenue
$1.1Mmissed by $500.0K
Consensus: $1.6M
Diluted EPS
$-2.11missed by $1.31
Consensus: $-0.80
SEC

SEC Filings

Earnings release8-K · 0001193125-26-223985
Annual report10-K/A · 0001193125-26-197315

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Arcadia Biosciences's Q1 2026 earnings report.

Arcadia Biosciences (RKDA) reported Q1 2026 earnings on May 14, 2026 before market open.

Arcadia Biosciences reported revenue of $1.1M and diluted EPS of $-2.11 for Q1 2026.

Revenue missed the consensus estimate of $1.6M by $500.0K. EPS missed the consensus estimate of $-0.80 by $1.31.

Compared to the same quarter a year prior, revenue declined 8.3% from $1.2M a year earlier.

You can read the 8-K earnings release (0001193125-26-223985) and the 10-K/A periodic report (0001193125-26-197315) directly on SEC EDGAR. The filing index links above go to sec.gov.